Advancements in Lymphoma and Leukaemia – an expert view
17:30 – 20:30
|Professor Christopher Fegan
University Hospital of Wales
The full programme can be viewed HERE
Who should attend?
This meeting is ideal for:
- Researchers and
and any healthcare professionals who have an interest in the future shape and direction of FL & CLL research and treatment.
‘Advancements in Lymphoma and Leukaemia – an expert view’ (code: 121975) has been approved by the Federation of the Royal Colleges of Physicians of the United Kingdom for 2 category 1 (external) CPD credit(s). Please note, CPD credits obtained through RCP will be accepted by other medical colleges such as the Royal College of Pathologists and the Royal College of Nursing.
When & Where
Tuesday 9th October 2018, 17:30 – 20:30
Miskin Manor Hotel
The meeting costs are underwritten by Gilead Sciences Ltd. and the event is free of charge for healthcare professionals to attend. Places are strictly limited by room capacity.
Date of preparation: June 2019
This activity is intended for medical Haematology/Oncology healthcare professionals, scientists and academics involved in the management of, and research into CAR T-cell therapy in patients with high-grade lymphoid malignancies, specifically relapsed/refractory diffuse large B-cell lymphoma (DLBCL) and primary mediastinal large B-cell lymphoma (PMBCL), as well as those with interest in the wider treatment landscape of haematological malignancies. Data on licensed CAR-T products will be presented.